{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T20:08:19Z","timestamp":1773173299283,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-026-04582-y","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T01:57:39Z","timestamp":1773107859000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and Ultrasonographic Characterization of the Transition from Hashimoto Thyroiditis to Graves' Disease: A Long-term Follow-up Study"],"prefix":"10.1007","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8633-7700","authenticated-orcid":false,"given":"Alberto","family":"Vassallo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6117-0081","authenticated-orcid":false,"given":"Luigi","family":"di Filippo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0010-0998","authenticated-orcid":false,"given":"Francesca","family":"Perticone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Castellino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6783-3398","authenticated-orcid":false,"given":"Andrea","family":"Giustina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5545-550X","authenticated-orcid":false,"given":"Paola","family":"Loli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"4582_CR1","doi-asserted-by":"publisher","unstructured":"S. Bliddal, C.H. Nielsen, U. Feldt-Rasmussen, Recent advances in Understanding autoimmune thyroid disease: the tallest tree in the forest of polyautoimmunity. F1000Res 2017;6. https:\/\/doi.org\/10.12688\/f1000research.11535.1","DOI":"10.12688\/f1000research.11535.1"},{"key":"4582_CR2","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/cei.12980","volume":"189","author":"T Diana","year":"2017","unstructured":"T. Diana, J. Krause, P.D. Olivo, J. K\u00f6nig, M. Kanitz, B. Decallonne et al., Prevalence and clinical relevance of thyroid stimulating hormone receptor-blocking antibodies in autoimmune thyroid disease. Clin. Exp. Immunol. 189, 304\u2013309 (2017). https:\/\/doi.org\/10.1111\/cei.12980","journal-title":"Clin. Exp. Immunol."},{"key":"4582_CR3","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/j.1365-2265.1990.tb03906.x","volume":"33","author":"N Takasu","year":"1990","unstructured":"N. Takasu, T. Yamada, A. Sato, M. Nakagawa, I. Komiya, Y. Nagasawa et al., Graves\u2019 disease following hypothyroidism due to hashimoto\u2019s disease: studies of eight cases. Clin. Endocrinol. (Oxf). 33, 687\u2013698 (1990). https:\/\/doi.org\/10.1111\/j.1365-2265.1990.tb03906.x","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"4582_CR4","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s12020-023-03634-x","volume":"84","author":"A Vassallo","year":"2024","unstructured":"A. Vassallo, F. Ferrari, di L. Filippo, A. Giustina, P. Loli, Transition from Hashimoto thyroiditis to graves\u2019s disease: an unpredictable. change? Endocr. 84, 541\u2013548 (2024). https:\/\/doi.org\/10.1007\/s12020-023-03634-x","journal-title":"change? Endocr."},{"key":"4582_CR5","first-page":"40","volume":"83","author":"L. Chiovato","year":"1998","unstructured":"L. Chiovato, E. Fiore, P. Vitti, R. Rocchi, T. Rago, D. Dokic et al., Outcome of thyroid function in graves\u2019 patients treated with radioiodine: role of thyroid-Stimulating and Thyrotropin-Blocking antibodies and of Radioiodine-Induced thyroid Damage*. J. Clin. Endocrinol. Metab. 83, 40\u201346 (1998)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4582_CR6","doi-asserted-by":"publisher","first-page":"609","DOI":"10.20945\/2359-3997000000086","volume":"62","author":"B Gonzalez-Aguilera","year":"2018","unstructured":"B. Gonzalez-Aguilera, D. Betea, L. Lutteri, E. Cavalier, V. Geenen, A. Beckers et al., Conversion to graves disease from Hashimoto thyroiditis: a study of 24 patients. Arch. Endocrinol. Metab. 62, 609\u2013614 (2018). https:\/\/doi.org\/10.20945\/2359-3997000000086","journal-title":"Arch. Endocrinol. Metab."},{"key":"4582_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1089\/thy.2012.0374","volume":"23","author":"SM McLachlan","year":"2013","unstructured":"S.M. McLachlan, B. Rapoport, Thyrotropin-Blocking autoantibodies and Thyroid-Stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versa. Thyroid. 23, 14\u201324 (2013). https:\/\/doi.org\/10.1089\/thy.2012.0374","journal-title":"Thyroid"},{"key":"4582_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/182176","volume":"2012","author":"N Takasu","year":"2012","unstructured":"N. Takasu, M. Matsushita, Changes of TSH-Stimulation blocking antibody (TSBAb) and thyroid stimulating antibody (TSAb) over 10 years in 34 TSBAb-Positive patients with hypothyroidism and in 98 TSAb-Positive graves\u2019 patients with hyperthyroidism: Reevaluation of TSBAb and TSAb in TSH-Receptor-Antibody (TRAb)-Positive patients. J. Thyroid Res. 2012, 1\u201311 (2012). https:\/\/doi.org\/10.1155\/2012\/182176","journal-title":"J. Thyroid Res."},{"key":"4582_CR9","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1515\/cclm-2022-0162","volume":"60","author":"M Giannone","year":"2022","unstructured":"M. Giannone, M. Dalla Costa, C. Sabbadin, S. Garelli, M. Salv\u00e0, S. Masiero et al., TSH-receptor autoantibodies in patients with chronic thyroiditis and hypothyroidism. Clin. Chem. Lab. Med. 60, 1020\u20131030 (2022). https:\/\/doi.org\/10.1515\/cclm-2022-0162","journal-title":"Clin. Chem. Lab. Med."},{"key":"4582_CR10","doi-asserted-by":"publisher","first-page":"101631","DOI":"10.1016\/j.beem.2022.101631","volume":"37","author":"F Azizi","year":"2023","unstructured":"F. Azizi, H. Abdi, A. Amouzegar, A.S. Habibi Moeini, Long-term thionamide antithyroid treatment of graves\u2019 disease. Best Pract. Res. Clin. Endocrinol. Metab. 37, 101631 (2023). https:\/\/doi.org\/10.1016\/j.beem.2022.101631","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"4582_CR11","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1210\/clinem\/dgad538","volume":"109","author":"A-E Meling Stokland","year":"2024","unstructured":"A.-E. Meling Stokland, M. Austdal, B.G. Nedreb\u00f8, S. Carlsen, H.B. Hetland, L. Breivik et al., Outcomes of patients with graves disease 25 years after initiating antithyroid drug therapy. J. Clin. Endocrinol. Metab. 109, 827\u2013836 (2024). https:\/\/doi.org\/10.1210\/clinem\/dgad538","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4582_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3803\/EnM.2019.34.1.29","volume":"34","author":"WM Wiersinga","year":"2019","unstructured":"W.M. Wiersinga, Graves\u2019 disease: can it be cured? Endocrinol. Metabolism. 34, 29\u201338 (2019). https:\/\/doi.org\/10.3803\/EnM.2019.34.1.29","journal-title":"Endocrinol. Metabolism"},{"key":"4582_CR13","first-page":"31","volume":"42","author":"H Umar","year":"2010","unstructured":"H. Umar, N. Muallima, J.M.F. Adam, H. Sanusi, Hashimoto\u2019s thyroiditis following graves\u2019 disease. Acta Med. Indones. 42, 31\u201335 (2010)","journal-title":"Acta Med. Indones"},{"key":"4582_CR14","unstructured":"L.C. Wood, S.H. Ingbar, Hypothyroidism as a Late Sequela in Patients with Graves\u2019 Disease Treated with Antithyroid Agents. n.d"},{"key":"4582_CR15","doi-asserted-by":"publisher","unstructured":"H. Mahmoud, A. Alsanory, H. Mostafa, E. Hassan, Factors affecting timing of hypothyroidism following radioactive iodine therapy (RAIT) for patients with graves\u2019 disease: A 12-month observational study. Nucl. Med. Commun. 45 (2024). https:\/\/doi.org\/10.1097\/MNM.0000000000001838","DOI":"10.1097\/MNM.0000000000001838"},{"key":"4582_CR16","doi-asserted-by":"publisher","unstructured":"H. Vargas-Uricoechea, J.P. Nogueira, M.V. Pinz\u00f3n-Fern\u00e1ndez, D. Schwarzstein, The usefulness of thyroid antibodies in the diagnostic approach to autoimmune thyroid disease. Antibodies 2023;12. https:\/\/doi.org\/10.3390\/antib12030048","DOI":"10.3390\/antib12030048"},{"key":"4582_CR17","doi-asserted-by":"publisher","unstructured":"E. Ahmad, K. Hafeez, M.F. Arshad, J. Isuga, A. Vrettos, Hypothyroidism conversion to hyperthyroidism: it\u2019s never too late. Endocrinol Diabetes Metab Case Rep 2018;2018. https:\/\/doi.org\/10.1530\/EDM-18-0047","DOI":"10.1530\/EDM-18-0047"},{"key":"4582_CR18","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/j.1365-2265.2012.04397.x","volume":"77","author":"C Kamath","year":"2012","unstructured":"C. Kamath, S. Young, K. Kabelis, J. Sanders, M.A. Adlan, J. Furmaniak et al., Thyrotrophin receptor antibody characteristics in a woman with long-standing hashimoto\u2019s who developed graves\u2019 disease and pretibial myxoedema. Clin. Endocrinol. (Oxf). 77, 465\u2013470 (2012). https:\/\/doi.org\/10.1111\/j.1365-2265.2012.04397.x","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"4582_CR19","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0531-5565(98)00030-8","volume":"33","author":"S Mariotti","year":"1998","unstructured":"S. Mariotti, L. Chiovato, C. Franceschi, A. Pinchera, Thyroid autoimmunity and aging. Exp. Gerontol. 33, 535\u2013541 (1998). https:\/\/doi.org\/https:\/\/https:\/\/doi.org\/10.1016\/S0531-5565(98)00030-8","journal-title":"Exp. Gerontol."},{"key":"4582_CR20","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1159\/000184239","volume":"43","author":"A Pinchera","year":"2008","unstructured":"A. Pinchera, S. Mariotti, G. Barbesino, R. Bechi, P. Sansoni, U. Fagiolo et al., Thyroid Autoimmun. Ageing Horm. Res. 43, 64\u201368 (2008). https:\/\/doi.org\/10.1159\/000184239","journal-title":"Thyroid Autoimmun. Ageing Horm. Res."},{"key":"4582_CR21","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.clim.2013.02.010","volume":"149","author":"R Bove","year":"2013","unstructured":"R. Bove, Autoimmune diseases and reproductive aging. Clin. Immunol. 149, 251\u2013264 (2013). https:\/\/doi.org\/10.1016\/j.clim.2013.02.010","journal-title":"Clin. Immunol."},{"key":"4582_CR22","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/BF03345556","volume":"29","author":"M Gola","year":"2006","unstructured":"M. Gola, M. Doga, G. Mazziotti, S. Bonadonna, A. Giustina, Development of graves\u2019 hyperthyroidism during the early phase of pregnancy in a patient with pre-existing and long-standing hashimoto\u2019s hypothyroidism. J. Endocrinol. Invest. 29, 288\u2013290 (2006). https:\/\/doi.org\/10.1007\/BF03345556","journal-title":"J. Endocrinol. Invest."},{"key":"4582_CR23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s40618-019-01094-7","volume":"43","author":"M Rotondi","year":"2020","unstructured":"M. Rotondi, C. Virili, S. Pinto, F. Coperchini, L. Croce, N. Brusca et al., The clinical phenotype of graves\u2019 disease occurring as an isolated condition or in association with other autoimmune diseases. J. Endocrinol. Invest. 43, 157\u2013162 (2020). https:\/\/doi.org\/10.1007\/s40618-019-01094-7","journal-title":"J. Endocrinol. Invest."},{"key":"4582_CR24","doi-asserted-by":"publisher","first-page":"e227445","DOI":"10.1136\/bcr-2018-227445","volume":"12","author":"AR Kafrouni Gerges","year":"2019","unstructured":"A.R. Kafrouni Gerges, S.N. Clark, H. Shawa, Hypothyroidism to hyperthyroidism: an immunological pendulum swing from two extreme poles \u2013 a case series. BMJ Case Rep. 12, e227445 (2019). https:\/\/doi.org\/10.1136\/bcr-2018-227445","journal-title":"BMJ Case Rep."},{"key":"4582_CR25","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1055\/s-0035-1559648","volume":"47","author":"J Furmaniak","year":"2015","unstructured":"J. Furmaniak, J. Sanders, R. N\u00fa\u00f1ez Miguel, B. Rees Smith, Mechanisms of action of TSHR autoantibodies. Horm. Metab. Res. 47, 735\u2013752 (2015). https:\/\/doi.org\/10.1055\/s-0035-1559648","journal-title":"Horm. Metab. Res."},{"key":"4582_CR26","doi-asserted-by":"publisher","unstructured":"N. Daramjav, J. Takagi, H. Iwayama, K. Uchino, D. Inukai, K. Otake et al., Autoimmune thyroiditis shifting from hashimoto\u2019s thyroiditis to graves\u2019 disease. Med. (Lithuania). 59 (2023). https:\/\/doi.org\/10.3390\/medicina59040757","DOI":"10.3390\/medicina59040757"},{"key":"4582_CR27","doi-asserted-by":"publisher","first-page":"4742","DOI":"10.1210\/jc.2009-1243","volume":"94","author":"SB Feingold","year":"2009","unstructured":"S.B. Feingold, J. Smith, J. Houtz, E. Popovsky, R.S. Brown, Prevalence and functional significance of Thyrotropin receptor blocking antibodies in children and adolescents with chronic lymphocytic thyroiditis. J. Clin. Endocrinol. Metab. 94, 4742\u20134748 (2009). https:\/\/doi.org\/10.1210\/jc.2009-1243","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4582_CR28","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1210\/jcem-64-2-239","volume":"64","author":"N TAKASU","year":"1987","unstructured":"N. TAKASU, T. YAMADA, M. KATAKURA, K. YAMAUCHI, Y. SHIMIZU, Y. ISHIZUKI, Evidence for Thyrotropin (TSH)-Blocking activity in goitrous hashimoto\u2019s thyroiditis with assays measuring Inhibition of TSH receptor binding and TSH-Stimulated thyroid adenosine 3\u2032,5\u2032-Monophosphate Responses\/Cell growth by Immunoglobulins. J. Clin. Endocrinol. Metab. 64, 239\u2013245 (1987). https:\/\/doi.org\/10.1210\/jcem-64-2-239","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4582_CR29","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/BF03348154","volume":"10","author":"L Chiovato","year":"1987","unstructured":"L. Chiovato, P. Vitti, A. Lombardi, G. Lopez, F. Santini, E. Macchia et al., Detection and characterization of autoantibodies blocking the TSH-dependent cAMP production using FRTL-5 cells. J. Endocrinol. Invest. 10, 383\u2013388 (1987). https:\/\/doi.org\/10.1007\/BF03348154","journal-title":"J. Endocrinol. Invest."},{"key":"4582_CR30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1210\/jcem-71-1-40","volume":"71","author":"L CHIOVATO","year":"1990","unstructured":"L. CHIOVATO, P. VITTI, F. SANTINI, G. LOPEZ, C. MAMMOLI, P. BASSI et al., Incidence of antibodies blocking Thyrotropin effect in vitro in patients with euthyroid or hypothyroid autoimmune Thyroiditis*. J. Clin. Endocrinol. Metab. 71, 40\u201345 (1990). https:\/\/doi.org\/10.1210\/jcem-71-1-40","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4582_CR31","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1210\/jcem.81.2.8636282","volume":"81","author":"M Rieu","year":"1996","unstructured":"M. Rieu, C. Portos, B. Lissak, S. Laplanche, B. Sambor, J.L. Berrod et al., Relationship of antibodies to Thyrotropin receptors and to thyroid ultrasonographic volume in euthyroid and hypothyroid patients with autoimmune thyroiditis. J. Clin. Endocrinol. Metab. 81, 641\u2013645 (1996). https:\/\/doi.org\/10.1210\/jcem.81.2.8636282","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4582_CR32","doi-asserted-by":"publisher","unstructured":"L. Jara, G. Medina, M. Cruz-Dominguez, A. Sol\u00eds, O. Vera-Lastra, M. Saavedra, Atrophic Autoimmune Thyroiditis, 2025, pp. 345\u201350. https:\/\/doi.org\/10.1007\/978-3-031-69895-8_47","DOI":"10.1007\/978-3-031-69895-8_47"},{"key":"4582_CR33","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1056\/NEJM199202203260803","volume":"326","author":"N Takasu","year":"1992","unstructured":"N. Takasu, T. Yamada, M. Takasu, I. Komiya, Y. Nagasawa, T. Asawa et al., Disappearance of Thyrotropin-Blocking antibodies and spontaneous recovery from hypothyroidism in autoimmune thyroiditis. N. Engl. J. Med. 326, 513\u2013518 (1992). https:\/\/doi.org\/10.1056\/NEJM199202203260803","journal-title":"N. Engl. J. Med."},{"key":"4582_CR34","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1365-2265.1992.tb00960.x","volume":"36","author":"Z Kralem","year":"1992","unstructured":"Z. Kralem, E. Baron, L. Kahana, O. Sadeh, M. Shelnfeld, Changes in stimulating and blocking TSH receptor antibodies in a patient undergoing three cycles of transition from hypo to hyper-thyroidism and back to hypothyroidism. Clin. Endocrinol. (Oxf). 36, 211\u2013214 (1992). https:\/\/doi.org\/10.1111\/j.1365-2265.1992.tb00960.x","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"4582_CR35","doi-asserted-by":"publisher","unstructured":"G. Napolitano, I. Bucci, Di G. Dalmazi, C. Giuliani, Non-Conventional clinical uses of TSH receptor antibodies: the case of chronic autoimmune thyroiditis. Front. Endocrinol. (Lausanne). 12 (2021). https:\/\/doi.org\/10.3389\/fendo.2021.769084","DOI":"10.3389\/fendo.2021.769084"},{"key":"4582_CR36","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1055\/a-0723-9023","volume":"50","author":"T Diana","year":"2018","unstructured":"T. Diana, P.D. Olivo, G.J. Kahaly, Thyrotropin receptor blocking antibodies. Horm. Metab. Res. 50, 853\u2013862 (2018). https:\/\/doi.org\/10.1055\/a-0723-9023","journal-title":"Horm. Metab. Res."},{"key":"4582_CR37","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4158\/EP-2019-0363","volume":"26","author":"GJ Kahaly","year":"2020","unstructured":"G.J. Kahaly, T. Diana, P.D. Olivo, TSH receptor antibodies: relevance & utility. Endocr. Pract. 26, 97\u2013106 (2020). https:\/\/doi.org\/10.4158\/EP-2019-0363","journal-title":"Endocr. Pract."},{"key":"4582_CR38","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1089\/thy.2015.0031","volume":"25","author":"KA Ponto","year":"2015","unstructured":"K.A. Ponto, H. Binder, T. Diana, N. Matheis, A.F. Otto, S. Pitz et al., Prevalence, Phenotype, and psychosocial Well-Being in Euthyroid\/Hypothyroid Thyroid-Associated orbitopathy. Thyroid\u00ae. 25, 942\u2013948 (2015). https:\/\/doi.org\/10.1089\/thy.2015.0031","journal-title":"Thyroid\u00ae"},{"key":"4582_CR39","doi-asserted-by":"publisher","unstructured":"L. Bartalena, E. Piantanida, D. Gallo, A. Lai, M.L. Tanda, N. Epidemiology, History, Risk Factors, and prevention of graves\u2019 orbitopathy. Front. Endocrinol. (Lausanne). 11 (2020). https:\/\/doi.org\/10.3389\/fendo.2020.615993","DOI":"10.3389\/fendo.2020.615993"},{"key":"4582_CR40","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3803\/EnM.2019.34.3.268","volume":"34","author":"YM Choi","year":"2019","unstructured":"Y.M. Choi, M.K. Kwak, S.M. Hong, E.G. Hong, Changes in thyroid peroxidase and thyroglobulin antibodies might be associated with graves\u2019 disease relapse after antithyroid drug therapy. Endocrinol. Metabolism. 34, 268\u2013274 (2019). https:\/\/doi.org\/10.3803\/EnM.2019.34.3.268","journal-title":"Endocrinol. Metabolism"},{"key":"4582_CR41","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1046\/j.1365-2265.2003.01726.x","volume":"58","author":"H Tada","year":"2003","unstructured":"H. Tada, I. Mizuta, T. Takano, K. Tatsumi, Y. Izumi, Y. Hidaka et al., Blocking-type anti-TSH receptor antibodies and relation to responsiveness to antithyroid drug therapy and remission in graves\u2019 disease. Clin. Endocrinol. (Oxf). 58, 403\u2013408 (2003). https:\/\/doi.org\/10.1046\/j.1365-2265.2003.01726.x","journal-title":"Clin. Endocrinol. (Oxf)"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04582-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-026-04582-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04582-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T01:57:44Z","timestamp":1773107864000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-026-04582-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4582"],"URL":"https:\/\/doi.org\/10.1007\/s12020-026-04582-y","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]},"assertion":[{"value":"22 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All adult patients (age\u2009\u2265\u200918 years) affected by autoimmune thyroid disorders were included in an epidemiologic monocentric register approved by the Local Ethics Committee complying with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"A signed informed consent was obtained for all patients participating in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"110"}}